domingo, 21 de diciembre de 2025
From pig to patient Pioneering transplants from pigs to humans could mark a turning point for organ replacement. +++++ +
https://www.drugdiscoverynews.com/from-pig-to-patient-16896
Biologic therapies push pharma to rethink inactive ingredients
As therapies grow more complex, inactive ingredient innovation is needed to improve drug impact and access.
https://www.drugdiscoverynews.com/biologic-therapies-push-pharma-to-rethink-inactive-ingredients-16887
Targeting viral entry to expand antiviral drug discovery strategies
New study uses simulations and machine learning to identify a single, high-impact interaction within a viral fusion protein, highlighting a potential new target for antiviral drug development.
https://www.drugdiscoverynews.com/targeting-viral-entry-to-expand-antiviral-drug-discovery-strategies-16902
AI helps radiologists find breast cancers earlier and faster
Rather than replacing radiologists, AI is working alongside them to catch cancers earlier and improve screening efficiency.
https://www.drugdiscoverynews.com/ai-helps-radiologists-find-breast-cancers-earlier-and-faster-16830
Experimental treatments strike at a key mutation in deadly cancers
Early clinical trials show that a KRAS G12D inhibitor can shrink tumors in patients with advanced pancreatic and other solid cancers.
https://www.drugdiscoverynews.com/experimental-treatments-strike-at-a-key-mutation-in-deadly-cancers-16812?utm_campaign=DDN_Newsletter_Dose&utm_medium=email&_hsenc=p2ANqtz--YBActFA955r8tUoZKZouHeFjmXLHb5BwxpprPI4YMd70hXHzeR0l67qcG7FOuzuPyklbAAv4OIuHsqM5oiaFKETVWSQ&_hsmi=395306581&utm_content=395306581&utm_source=hs_email
Armoring up CAR T cells to fight solid tumors
ArsenalBio equips T cells with multiple weapons to identify, attack, and persist against tumors, bringing the power of CAR T cell technology to solid cancers.
https://www.drugdiscoverynews.com/armoring-up-car-t-cells-to-fight-solid-tumors-16276?utm_campaign=DDN_Newsletter_Dose&utm_medium=email&_hsenc=p2ANqtz-_6AyTJl4NEeeFiajbcBpwP7B4hlK3l5aj-reDn1YVsb9tJB3rXmQ1vsjsbFdoYIXu2isqaFdrC8nB9_Q3J4q4U9RfFDQ&_hsmi=395306581&utm_content=395306581&utm_source=hs_email
Suscribirse a:
Enviar comentarios (Atom)


No hay comentarios:
Publicar un comentario